| Trial ID: | L0659 |
| Source ID: | NCT00150566
|
| Associated Drug: |
Lanthanum Carbonate
|
| Title: |
Efficacy and Safety of Lanthanum in Controlling Serum Phosphate Levels in Subjects With End Stage Renal Disease Who Require Treatment for High Levels of Phosphate in Their Blood
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Kidney Failure, Chronic
|
| Interventions: |
DRUG: Lanthanum carbonate
|
| Outcome Measures: |
Primary: Pre-dialysis serum phosphate levels after 4 and 8 weeks of treatment, 4 & 8 weeks | Secondary: Tolerability, 8 weeks|Quality of Life, 8 weeks|Subject/physician satisfaction and preference questionnaires, 8 weeks
|
| Sponsor/Collaborators: |
Sponsor: Shire
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE3
|
| Enrollment: |
460
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT
|
| Start Date: |
2004-02-09
|
| Completion Date: |
2005-10-08
|
| Results First Posted: |
|
| Last Update Posted: |
2021-06-08
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT00150566
|
